BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 27864203)

  • 1. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
    Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
    Owusu-Obeng A; Weitzel KW; Hatton RC; Staley BJ; Ashton J; Cooper-Dehoff RM; Johnson JA
    Pharmacotherapy; 2014 Oct; 34(10):1102-12. PubMed ID: 25220280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics in the clinic.
    Relling MV; Evans WE
    Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists and their role in pharmacogenomics testing: an Australian perspective drawing on international evidence.
    Suppiah V; Lim CX; Hotham E
    Aust J Prim Health; 2018 Jan; 24(6):441-447. PubMed ID: 30409245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice.
    Wang YT; Merl MY; Yang J; Zhu ZX; Li GH
    Pharmacogenomics J; 2020 Apr; 20(2):169-178. PubMed ID: 31796890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.
    Valgus J; Weitzel KW; Peterson JF; Crona DJ; Formea CM
    Am J Health Syst Pharm; 2019 Apr; 76(8):521-529. PubMed ID: 31361863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
    Walko C; Kiel PJ; Kolesar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing.
    L Rogers S; Keeling NJ; Giri J; Gonzaludo N; Jones JS; Glogowski E; Formea CM
    Pharmacogenomics; 2020 Jul; 21(11):785-796. PubMed ID: 32748688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics to achieve precision medicine.
    Empey PE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1906-1907. PubMed ID: 27784662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.